Arthritis drug to be tested to treat coronavirus - (MarketWatch via NewsPoints Desk)

  • Sanofi and Regeneron Pharmaceuticals want to launch clinical trials to see whether their drug Kevzara, approved by the FDA in 2017 for rheumatoid arthritis, could treat symptoms of novel coronavirus infections, reported MarketWatch.

  • The research aims to see whether certain drugs already on the market to tackle immune disorders like rheumatoid arthritis could help ease damage to the lungs and respiratory system caused by the immune system's overreaction to the SARS-CoV-2 virus, rather than killing it.

  • "The goal would be in the next couple of weeks to have the trial up and running, and in weeks to months after that to have the data," said George Yancopoulos, chief scientific officer at Regeneron.

To read more NewsPoints articles, click here.

Reference Articles